• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动不足性肥厚型心肌病:新生儿自发性消退型的罕见病例。

Hypokinetic Hypertrophic Cardiomyopathy: A Rare Case of a Spontaneously Regressive Form in a Newborn.

作者信息

Lamouri Inasse, Ech-Chebab Mohammed, Ayyad Anass, Messaoudi Sahar, Babakhouya Abdeladim, Amrani Rim

机构信息

Department of Pediatrics, Faculty of Medicine and Pharmacy, Mohammed VI University Hospital, Mohammed I University, Maternal-Child and Mental Health Research Laboratory, Oujda, MAR.

Department of Neonatology and Intensive Care Unit, Faculty of Medicine and Pharmacy, Mohammed VI University Hospital, Mohammed I University, Oujda, MAR.

出版信息

Cureus. 2024 Jul 9;16(7):e64186. doi: 10.7759/cureus.64186. eCollection 2024 Jul.

DOI:10.7759/cureus.64186
PMID:39119430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11309815/
Abstract

Hypertrophic cardiomyopathy (HCM) of the newborn is a rare condition, characterized by great clinical variability, with a relative paucity of data on the pediatric population, especially newborns. Early diagnosis can have an impact on the patient's life course and prevent progression to sudden death. In this article, we report the case of a newborn admitted with late-onset neonatal respiratory distress, complicated by heart failure. The newborn was matured by two antenatal injections of betamethasone, which were received as part of a threat of premature delivery. Echocardiography revealed hypokinetic HCM. The rapidity of the establishment of the diagnosis contributed to the patient's survival and improvement within a few weeks under well-managed medical treatment. A complete workup was conducted, with negative results. The most suggested explanation for this condition was the use of antenatal corticosteroids.

摘要

新生儿肥厚型心肌病(HCM)是一种罕见疾病,其临床变异性很大,关于儿科人群尤其是新生儿的数据相对较少。早期诊断可能会影响患者的生命历程并预防进展为猝死。在本文中,我们报告了一例因迟发性新生儿呼吸窘迫入院且并发心力衰竭的新生儿病例。该新生儿通过两次产前注射倍他米松促胎肺成熟,这是作为早产威胁的一部分进行的。超声心动图显示为运动减弱型HCM。诊断的确立速度有助于患者在精心管理的药物治疗下数周内存活并好转。进行了全面检查,结果均为阴性。对此病症最可能的解释是产前使用了皮质类固醇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/906f67078177/cureus-0016-00000064186-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/2dd4065e8b39/cureus-0016-00000064186-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/180501961676/cureus-0016-00000064186-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/0530cc6ae6eb/cureus-0016-00000064186-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/906f67078177/cureus-0016-00000064186-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/2dd4065e8b39/cureus-0016-00000064186-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/180501961676/cureus-0016-00000064186-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/0530cc6ae6eb/cureus-0016-00000064186-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e69c/11309815/906f67078177/cureus-0016-00000064186-i04.jpg

相似文献

1
Hypokinetic Hypertrophic Cardiomyopathy: A Rare Case of a Spontaneously Regressive Form in a Newborn.运动不足性肥厚型心肌病:新生儿自发性消退型的罕见病例。
Cureus. 2024 Jul 9;16(7):e64186. doi: 10.7759/cureus.64186. eCollection 2024 Jul.
2
Myocardial infarction in a neonate with severe hypertrophic cardiomyopathy: a case report.新生儿重症肥厚型心肌病并发心肌梗死 1 例报告
Future Cardiol. 2023 Jun;19(7):375-381. doi: 10.2217/fca-2022-0130. Epub 2023 Aug 4.
3
Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids.多剂产前皮质类固醇激素治疗后新生儿的短暂性肥厚型心肌病
Am J Perinatol. 1999;16(1):17-21. doi: 10.1055/s-2007-993830.
4
Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.肥厚型心肌病的扩张-运动减退演变:儿科和成年患者中的患病率、发病率、危险因素及预后意义
J Am Coll Cardiol. 2005 Oct 18;46(8):1543-50. doi: 10.1016/j.jacc.2005.04.062. Epub 2005 Sep 28.
5
Neonatal hypertrophic cardiomyopathy with dyspnoea as the first symptom: a case report.以呼吸困难为首发症状的新生儿肥厚型心肌病:一例报告
Front Pediatr. 2023 Nov 29;11:1295539. doi: 10.3389/fped.2023.1295539. eCollection 2023.
6
Late preterm antenatal corticosteroids in singleton and twin gestations: a retrospective cohort study.单胎和双胎妊娠中晚期早产儿产前皮质类固醇治疗:一项回顾性队列研究。
BMC Pregnancy Childbirth. 2022 Dec 5;22(1):904. doi: 10.1186/s12884-022-05262-1.
7
Apical Hypertrophic Cardiomyopathy: A Fatal yet Underappreciated Variant of Hypertrophic Cardiomyopathy.心尖肥厚型心肌病:肥厚型心肌病的一种致命但未得到充分认识的变异型
Cureus. 2023 Dec 30;15(12):e51345. doi: 10.7759/cureus.51345. eCollection 2023 Dec.
8
Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type.基于类型的肥厚型心肌病患儿 30 年的结局
J Cardiol. 2022 Dec;80(6):557-562. doi: 10.1016/j.jjcc.2022.07.016. Epub 2022 Aug 10.
9
Time interval from late preterm antenatal corticosteroid administration to delivery and the impact on neonatal outcomes.从晚期早产儿产前皮质激素给药到分娩的时间间隔及其对新生儿结局的影响。
Am J Obstet Gynecol MFM. 2021 Sep;3(5):100426. doi: 10.1016/j.ajogmf.2021.100426. Epub 2021 Jun 18.
10
[Prevention of preterm birth complications by antenatal corticosteroid administration].[产前使用糖皮质激素预防早产并发症]
J Gynecol Obstet Biol Reprod (Paris). 2016 Dec;45(10):1399-1417. doi: 10.1016/j.jgyn.2016.09.008. Epub 2016 Oct 21.

本文引用的文献

1
Neonatal hypertrophic cardiomyopathy with dyspnoea as the first symptom: a case report.以呼吸困难为首发症状的新生儿肥厚型心肌病:一例报告
Front Pediatr. 2023 Nov 29;11:1295539. doi: 10.3389/fped.2023.1295539. eCollection 2023.
2
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.儿童一级亲属肥厚型心肌病临床筛查的检出率。
Circulation. 2019 Jul 16;140(3):184-192. doi: 10.1161/CIRCULATIONAHA.118.038846. Epub 2019 Apr 22.
3
[Neonatal hypertrophic cardiomyopathy of difficult etiologic diagnosis].
[病因诊断困难的新生儿肥厚型心肌病]
Pan Afr Med J. 2011;10:60. Epub 2011 Dec 19.
4
Hypertrophic cardiomyopathy: infants, children, and adolescents.肥厚型心肌病:婴儿、儿童及青少年
Congenit Heart Dis. 2012 Jan-Feb;7(1):84-92. doi: 10.1111/j.1747-0803.2011.00613.x. Epub 2012 Jan 6.
5
Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.儿童肥厚型心肌病的流行病学及特定病因结局:来自儿童心肌病注册研究的结果
Circulation. 2007 Feb 13;115(6):773-81. doi: 10.1161/CIRCULATIONAHA.106.621185. Epub 2007 Jan 29.
6
Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.甲基强的松龙治疗支气管肺发育不良的早产儿肥厚型心肌病。
Pediatrics. 2006 May;117(5):1866-7. doi: 10.1542/peds.2006-0055.
7
Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment.产前倍他米松治疗后早产新生儿循环糖皮质激素生物活性
J Clin Endocrinol Metab. 2004 Aug;89(8):3999-4003. doi: 10.1210/jc.2004-0013.
8
Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids.多剂产前皮质类固醇激素治疗后新生儿的短暂性肥厚型心肌病
Am J Perinatol. 1999;16(1):17-21. doi: 10.1055/s-2007-993830.
9
Iatrogenic neonatal hypertrophic cardiomyopathy.医源性新生儿肥厚型心肌病
Pediatr Cardiol. 1996 Sep-Oct;17(5):335-9. doi: 10.1007/s002469900075.